SCHEMBL24899529

SCHEMBL24899529

c1ccc(-c2nc(-c3ccccc3)nc(-c3cc(N(c4ccc5ccccc5c4)c4ccc5ccccc5c4)c4c(c3)oc3ccccc34)n2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.34
ALDH1A1 P00352 5/20 0.34
CYP1A2 P05177 4/20 0.34
HSD17B10 Q99714 4/20 0.34
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
TP53 P04637 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TSHR P16473 4/20 0.33
POLB P06746 2/20 0.33
TERT O14746 3/20 0.33
MAPT P10636 6/20 0.32
LMNA P02545 3/20 0.32
HTT P42858 1/20 0.32
CYP1A1 P04798 1/20 0.32
FYN P06241 1/20 0.32
MAPK3 P27361 1/20 0.32
AHR P35869 1/20 0.32
PAX8 Q06710 1/20 0.32
ABCG2 Q9UNQ0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24255633 0.98 CYP1A2 (0.33) KDM4EALDH1A1CYP1A2HSD17B10KMT2A
SCHEMBL24899530 0.97 KDM4E (0.34) KDM4EALDH1A1CYP1A2HSD17B10KMT2A
SCHEMBL22112385 0.93 CYP1A2 (0.38) KDM4EALDH1A1CYP1A2HSD17B10KMT2A
SCHEMBL24066167 0.92 KDM4E (0.37) KDM4EALDH1A1CYP1A2HSD17B10KMT2A
SCHEMBL22112395 0.89 TSHR (0.35) KDM4EALDH1A1CYP1A2HSD17B10KMT2A
SCHEMBL22112381 0.89 TSHR (0.35) KDM4EALDH1A1CYP1A2HSD17B10KMT2A
SCHEMBL22112392 0.89 TSHR (0.35) KDM4EALDH1A1CYP1A2HSD17B10KMT2A
SCHEMBL22112382 0.89 TSHR (0.35) KDM4EALDH1A1CYP1A2HSD17B10KMT2A
SCHEMBL26571741 0.89 ALDH1A1 (0.36) KDM4EALDH1A1HSD17B10KMT2AMEN1
SCHEMBL23597773 0.89 KDM4E (0.33) KDM4EALDH1A1CYP1A2HSD17B10KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230016632-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO.,LTD. (KR) 2023-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230016632-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE CYP1A1, CYP1B1, CRY1 KDM4E 3329/4885ALDH1A1 23/4885CYP1A2 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.